Blog: Nestle turns to Chinese medicine
Dean Best | 29 November 2012
In another sign the world's largest food maker is not just about Kit Kats, Nescafe or Maggi noodles, the Swiss food giant is now looking to use Chinese medicine in its fledgling health science business.
Nestle and pharma and healthcare group Chi-Med are going to team up and look into developing "nutritional and medicinal products" using botanical plants.
"This joint venture provides Nestlé Health Science with an opportunity to develop and commercialise truly innovative and scientifically validated botanical-based nutrition for personalised healthcare in gastrointestinal health," Luis Cantarell, president and CEO for Nestlé Health Science, said.
Hutchison MediPharma Limited, a subsidiary of Chi-Med, is already developing what Nestle called a "first-of-its-kind botanical product", to be taken orally, to manage moderate inflammatory bowel disease.
The venture may raise some eyebrows in the food industry but it is a sign Nestle is confident efforts to carve a third way between nutrition and pharmaceuticals will pay dividends in a world facing growing health challenges from non-communicable diseases and, in the developed world, ageing populations.
Almost a year after buying Dole Food Co.'s international packaged food and Asian fresh businesses, Japanese trading house Itochu Corp. has looked again to the wider agrifood sector to diversify its bu...
There has been an increase in M&A among companies in the food sector in recent months - and management consultants at EY expect to the trend to continue....
Nelson Peltz is not letting go. The US billionaire investor is continuing in his quest to get PepsiCo to split in two - and has reportedly suggested a proxy battle with the company could be on the hor...
just-food has launched a section on its website dedicated to interviewing internationally-ambitious small- and medium-sized enterprises. ...
- On the money: Unilever shifting into growth spots
- On the money: Danone denies strategy overhaul
- The just-food interview: Premier Foods CEO Darby
- Comment: Danone could be mulling strategy shift
- Why whole sector should take heed of meat scrutiny
- Unilever sees lacklustre H1 food sales
- Tyson sells Mexico, Brazil ops to JBS
- Danone H1 profits down but sticks to FY goals
- Hovis eyes Leicester bakery closure
- FSA ordered to carry out review on 2 Sisters